Literature DB >> 6156045

Kidney-specific allo- and autoantibodies in the alloantibody response to rat kidney: the use of kidney homogenate as a target for serological analysis.

D N Hart, J W Fabre.   

Abstract

LEW anti-DA kidney and DA anti-LEW kidney sera were assayed using an indirect 125I anti-immunoglobulin-binding assay with kidney homogenate as target. This allowed the full spectrum of antibodies to be analysed since the tissue used for immunization was the same as that used as the target in the serological analysis. It was found that around 80% of the LEW anti-DA kidney serum was directed at kidney-specific antigens, approximately half at a kidney-specific alloantigen, and half at a kidney-specific autoantigen. Only a small component, around 20% of the antibodies, was directed at major histocompatibility complex (MHC) antigens. In contrast, the DA anti-LEW kidney serum, which was much weaker, was directed entirely at autoantigens, and was more complex in that at least two autoantigens were involved. None of the DA and LEW kidney autoantibodies reacted with lymphocytes. The potential of this assay system for the study of tissue-specific antibodies, especially autoantibodies in man, is discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6156045      PMCID: PMC1536958     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  7 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Quantitative studies on the tissue distribution of Ia and SD antigens in the DA and Lewis rat strains.

Authors:  D N Hart; J W Fabre
Journal:  Transplantation       Date:  1979-02       Impact factor: 4.939

3.  The binding of anti-immunoglobulin antibodies to rat thymocytes and thoracic duct lymphocytes.

Authors:  J C Jensenius; A F Williams
Journal:  Eur J Immunol       Date:  1974-02       Impact factor: 5.532

4.  An extension of the 51Cr-release assay for the estimation of mouse cytotoxins.

Authors:  W Boyle
Journal:  Transplantation       Date:  1968-09       Impact factor: 4.939

5.  Antigens on mouse and rat lymphocytes recognized by rabbit antiserum against rat brain: the quantitative analysis of a xenogeneic antiserum.

Authors:  R J Morris; A F Williams
Journal:  Eur J Immunol       Date:  1975-04       Impact factor: 5.532

6.  Quantitative serological analysis of a rabbit anti-rat lymphocyte serum and preliminary biochemical characterisation of the major antigen recognised.

Authors:  J W Fabre; A F Williams
Journal:  Transplantation       Date:  1977-04       Impact factor: 4.939

7.  Autologous immune complex nephritis induced with renal tubular antigen. I. Identification and isolation of the pathogenetic antigen.

Authors:  T S Edgington; R J Glassock; F J Dixon
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

  7 in total
  4 in total

Review 1.  Immunologically mediated lesions of kidney tubules and interstitium in laboratory animals and in man.

Authors:  J R Brentjens; B Noble; G A Andres
Journal:  Springer Semin Immunopathol       Date:  1982

2.  Autoantibody against fibroblasts in renal transplant recipients: analysis by 51Cr-release assays.

Authors:  M Aprile; P Halloran; G Haddad; M Robinette
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

3.  Organ-specific IgM autoantibodies to liver, heart and brain in man: generalized occurrence and possible functional significance in normal individuals, and studies in patients with multiple sclerosis.

Authors:  A S Daar; J W Fabre
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

4.  Identification with a monoclonal antibody of a predominantly B lymphocyte-specific determinant of the human leukocyte common antigen. Evidence for structural and possible functional diversity of the human leukocyte common molecule.

Authors:  R Dalchau; J W Fabre
Journal:  J Exp Med       Date:  1981-04-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.